Comparison of Illegal Drug Use Pattern in Taiwan and Korea from 2006 To

Total Page:16

File Type:pdf, Size:1020Kb

Comparison of Illegal Drug Use Pattern in Taiwan and Korea from 2006 To Feng et al. Substance Abuse Treatment, Prevention, and Policy (2016) 11:34 DOI 10.1186/s13011-016-0078-x RESEARCH Open Access Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014 Ling-Yi Feng1, Wen-Jing Yu1, Wei-Ting Chang1, Eunyoung Han2, Heesun Chung3* and Jih-Heng Li1* Abstract Background: Illegal drug use has long been a global concern. Taiwan and Korea are geographically adjacent and both countries have experienced the illegal use problems of methamphetamine, a predominant prototype of New Psychoactive Substances (NPS). NPS, a term coined by the United Nations Office on Drugs and Crime (UNODC) in recent years, have not been scrutinized for their safety and may become a new threat to public health and security worldwide. To conduct evidence-based drug policy, it is imperative to estimate the trend and pattern of illegal drug use. Therefore, this study aims to analyze and compare the current status of drug-related seizures, arrests and illegal drug use, with a focus on methamphetamine and NPS, between Taiwan and Korea. Methods: Data of illegal drug (including NPS)-related seizures and arrests were collected via anti-drug related agencies of both countries from 2006 through 2014.Since listing of NPS as controlled substances was a result of NPS abuse liability through official evaluation, the items of controlled NPS were used as an indicator of emerging use. These data obtained from Taiwan and Korea was then compared. Results: The results showed that while methamphetamine remained as a predominant drug in both Taiwan and Korea for decades, different illegal drug use patterns have been observed in these two countries. In Taiwan, the major illegal drugs were methamphetamine, heroin, and ketamine, whereas in Korea those were methamphetamine and cannabis. By comparison of per capita illicit drug seizures, the illegal drug use situation in Taiwan was at a higher stake than that in Korea. In terms of NPS use, ketamine has been a major drug in Taiwan, but it was seldom found in Korea. Besides ketamine, the major type of NPS was synthetic cathinones in Taiwan whereas it was synthetic cannabinoids and phenethylamines in Korea. The difference in the numbers of controlled NPS items between Taiwan (23) and Korea (93) may be due to the implementation of temporary control on NPS in Korea since 2011. Conclusion: While the problem of methamphetamine still lingers, NPS have emerged as a new issue in both countries. However, the NPS pattern was different between Taiwan and Korea. Although the controlled NPS items in Taiwan were far less than those in Korea, the quantity of total NPS seizures, especially with ketamine, was much larger in Taiwan than in Korea. Different NPS pattern may also imply they were from different sources. Factors other than geographical proximity, such as drug policy and availability and accessibility to drugs, should be taken into account for the current status of illegal drug use in Korea and Taiwan. Keywords: New Psychoactive Substances (NPS), Drug seizures, Ketamine, Methamphetamine, Taiwan, Korea * Correspondence: [email protected]; [email protected] 3Graduate School of Analytical Science and Technology(GRAST), Chungnam National University, 99- Daehak-ro, Yuseongk-gu, Daejeon 305-764, Korea 1School of Pharmacy and Ph.D. Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung City 80708, Taiwan Full list of author information is available at the end of the article © 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Feng et al. Substance Abuse Treatment, Prevention, and Policy (2016) 11:34 Page 2 of 13 Background heroin still lingering, other major illicit drugs such as Humans have experienced a long history of drug (or ketamine and MDMA have emerged since the past decade substance) use. To tackle the profound drug-related [5, 14, 15]. In addition, illegal use of NPS other than keta- issue, the United Nations has promulgated three inter- mine, such as some synthetic cannabinoids [e.g., JWH- national anti-drug conventions in the twentieth century, 250(K2), JWH-018(K2)], synthetic cathinones [e.g., mephe- namely, the 1961 Single Convention on Narcotic Drugs, drone, MDPV (methylenedioxypyrovalerone)] and Salvia the 1971 Convention on Psychotropic Substances, and (Salvia divinorum) has also been reported [13, 16, 17]. the 1988 Convention against Illicit Traffic in Narcotic Hence, illicit drugs consumed in Taiwan include not only Drugs and Psychotropic Substances [1–3]. These three the items in the 1961 Convention such as heroin, those in anti-drug Conventions provide legal mechanisms for the the 1971 Convention such as methamphetamine and control of narcotics, psychotropic substances and pre- MDMA, but also the NPS items such as ketamine, syn- cursors. According to the 2015 World Drug Report of thetic cannabinoids and cathinones. United Nations Office on Drugs and Crime (UNODC), In Korea, the top three illicit drugs were methampheta- cannabis, opioids/opiates and amphetamine-type stimu- mine, cannabis and opiates in 2004 [18]. Synthetic drugs lants (ATS) are currently the top three illicit drugs such as MDMA, Yaba, and LSD were found in greater worldwide [4]. However, reviews on the major illicit drug proportion in the seizure records. The misuse of common use situation in some Asian countries, such as China, medicines, such as dextromethorphan, zipeprol, and cari- India, Japan, Malaysia, Taiwan, and Vietnam, showed soprodol, was also found among young people because of that although these three illicit drugs have been most their easy availability. In recent years, seizures of NPS, prevalent in general, ATS is not a favorable drug in such as the synthetic cannabinoids JWH-018 or the plant- India, organic solvent replaces opioids/opiates as one of based substance kratom, have been reported in Korea. the top three illicit drugs in Japan, and ketamine replaces Synthetic cannabinoids (JWH-018 and its analogues), first cannabis in both China and Taiwan [5–7]. These studies detected in 2008 [19], have been identified as an emerging indicate that the status of illegal drug use may vary from threat in Korea. Synthetic cannabinoids accounted for one country to another. Thus, evaluation of illegal drug 71 % of total confiscated new drugs, followed by 18 % of use situation at individual country level is necessary to phenethylamines, 7 % of piperazines and4% of tryptamines solve unique drug problems in each country. [20]. Traditional drugs, including heroin and cocaine, are In recent years, the UNODC has warned the emergence not commonly used in Korea as reflected by drug seizure of new psychoactive substances (NPS) [8, 9]. NPS are classi- and arrest data [19]. Therefore, the illegal drug use situ- fied by the UNODC as synthetic cannabinoids, synthetic ation may have changed over the last decade in Korea. cathinones, ketamine and PCP-type substances, phenethyla- However, comprehensive and updated information has mines, piperazines, tryptamines, aminoindanes, plant-based not yet been available. substances and others [10]. They are not only dangerous to Methamphetamine, a member of the phenethylamine individual health but also intimidating to public health and family, can be regarded as a prototype of NPS. Since both social security due to their uncertain toxicological profiles Taiwan and Korea have been the victims of methampheta- [11–13].TheNPSusehasbecomeanewglobalchallenge mine use problems for decades, the outcomes of their drug because they are predominantly derivatives or analogues of policy and countermeasures have not been thoroughly existing controlled substances and remain mostly elusive approached. Illegal ketamine use has recently become a from the UN Conventions. serious problem in Taiwan. However, the illegal drug use In Taiwan, heroin and methamphetamine have been the data has not been incorporated into the reports of the predominant illicit drugs since 1990s. HIV infection by United Nations because Taiwan is currently not a member needle/solution sharing among heroin injecting users of the UN. According to the latest annual report of Taiwan surged in the early 2000s but was contained within a Food and Drug Administration (TFDA), the amounts of decade after implementation of harm reduction measures ketamine seizure increased sharply in Taiwan in recent [11]. Methamphetamine, a schedule II substance listed in years [21] and the sources of ketamine mainly originated the 1971 Convention on Psychotropic Substances, was from China and India. Ketamine seized in Indonesia and originally a pharmaceutical that was legally manufactured Japan was perceived to originate from China and/or India but widely misused in Japan after World War II. Illegal between 2008 and 2012 [22]. Since Korea is geographic- use of methamphetamine then spread to Republic of ally adjacent to China, Taiwan and Japan, it would also Korea (a.k.a South Korea, hereby abbreviated as Korea) be of interest to explore if Korea is currently
Recommended publications
  • Misuse of Drugs Act (MEI 2013).Fm
    LAWS OF BRUNEI CHAPTER 27 MISUSE OF DRUGS 7 of 1978 9 of 1979 1984 Edition, Chapter 27 Amended by 10 of 1982 S 27/1982 S 20/1984 S 8/1987 S 36/1987 S 20/1989 S 24/1991 S 20/1992 S 28/1994 S 42/1998 S 60/1999 2001 Edition, Chapter 27 Amended by S 7/2002 S 59/2007 S 5/2008 S 12/2010 S 12/2012 REVISED EDITION 2013 B.L.R.O. 2/2013 LAWS OF BRUNEI Misuse of Drugs CAP. 27 1 LAWS OF BRUNEI REVISED EDITION 2013 CHAPTER 27 MISUSE OF DRUGS ARRANGEMENT OF SECTIONS Section PART I PRELIMINARY 1. Citation. 2. Interpretation. 2A. Appointment of Director and other officers of Bureau. 2B. Public servants. 2C. Powers of investigations of Bureau. 2D. Use of weapons. PART II OFFENCES INVOLVING CONTROLLED DRUGS 3. Trafficking in controlled drug. 3A. Possession for purpose of trafficking. 4. Manufacture of controlled drug. 5. Importation and exportation of controlled drug. B.L.R.O. 2/2013 LAWS OF BRUNEI 2 CAP. 27 Misuse of Drugs 6. Possession and consumption of controlled drug. 6A. Consumption of controlled drug outside Brunei Darussalam by permanent resident. 6B. Place of consumption need not be stated or proven. 7. Possession of pipes, utensils etc. 8. Cultivation of cannabis, opium and coca plants. 8A. Manufacture, supply, possession, import or export of equipment, materials or substances useful for manufacture of controlled drugs. 8B. Regulations and controlled substances. 9. Responsibilities of owners and tenants etc. 10. Abetments and attempts punishable as offences. 11.
    [Show full text]
  • "Official Gazette of RM", No. 28/04 and 37/07), the Government of the Republic of Montenegro, at Its Meeting Held on ______2007, Enacted This
    In accordance with Article 6 paragraph 3 of the FT Law ("Official Gazette of RM", No. 28/04 and 37/07), the Government of the Republic of Montenegro, at its meeting held on ____________ 2007, enacted this DECISION ON CONTROL LIST FOR EXPORT, IMPORT AND TRANSIT OF GOODS Article 1 The goods that are being exported, imported and goods in transit procedure, shall be classified into the forms of export, import and transit, specifically: free export, import and transit and export, import and transit based on a license. The goods referred to in paragraph 1 of this Article were identified in the Control List for Export, Import and Transit of Goods that has been printed together with this Decision and constitutes an integral part hereof (Exhibit 1). Article 2 In the Control List, the goods for which export, import and transit is based on a license, were designated by the abbreviation: “D”, and automatic license were designated by abbreviation “AD”. The goods for which export, import and transit is based on a license designated by the abbreviation “D” and specific number, license is issued by following state authorities: - D1: the goods for which export, import and transit is based on a license issued by the state authority competent for protection of human health - D2: the goods for which export, import and transit is based on a license issued by the state authority competent for animal and plant health protection, if goods are imported, exported or in transit for veterinary or phyto-sanitary purposes - D3: the goods for which export, import and transit is based on a license issued by the state authority competent for environment protection - D4: the goods for which export, import and transit is based on a license issued by the state authority competent for culture.
    [Show full text]
  • Taiwan's Nationwide Cancer Registry System of 40 Years: Past, Present
    Journal of the Formosan Medical Association (2019) 118, 856e858 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.jfma-online.com Perspective Taiwan’s Nationwide Cancer Registry System of 40 years: Past, present, and future Chun-Ju Chiang a,b, Ying-Wei Wang c, Wen-Chung Lee a,b,* a Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan b Taiwan Cancer Registry, Taipei, Taiwan c Health Promotion Administration, Ministry of Health and Welfare, Taipei, Taiwan Received 29 October 2018; accepted 15 January 2019 The Taiwan Cancer Registry (TCR) is a nationwide demonstrate that the TCR is one of the highest-quality population-based cancer registry system that was estab- cancer registries in the world.3 lished by the Ministry of Health and Welfare in 1979. The The TCR publishes annual cancer statistics for all cancer data of patients with newly diagnosed malignant cancer in sites, and the TCR’s accurate data is used for policy making hospitals with 50 or more beds in Taiwan are collected and and academic research. For example, the Health Promotion reported to the TCR. To evaluate cancer care patterns and Administration (HPA) in Taiwan has implemented national treatment outcomes in Taiwan, the TCR established a long- screening programs for cancers of the cervix uteri, oral form database in which cancer staging and detailed treat- cavity, colon, rectum, and female breast,4 and the TCR ment and recurrence information has been recorded since database has been employed to verify the effectiveness of 2002. Furthermore, in 2011, the long-form database these nationwide cancer screening programs for reducing began to include detailed information regarding cancer cancer burdens in Taiwan.5,6 Additionally, liver cancer was site-specific factors, such as laboratory values, tumor once a major health problem in Taiwan; however, since the markers, and other clinical data related to patient care.
    [Show full text]
  • Pharmacogenetics of Ketamine Metabolism And
    Pharmacogenetics of Ketamine Metabolism and Immunopharmacology of Ketamine Yibai Li B.HSc. (Hons) Discipline of Pharmacology, School of Medical Sciences, Faculty of Health Sciences, The University of Adelaide September 2014 A thesis submitted for the Degree of PhD (Medicine) Table of contents TABLE OF CONTENTS .............................................................................................. I LIST OF FIGURES ....................................................................................................IV LIST OF TABLES ......................................................................................................IV ABSTRACT ............................................................................................................... V DECLARATION .......................................................................................................VIII ACKNOWLEDGEMENTS ..........................................................................................IX ABBREVIATIONS .....................................................................................................XI CHAPTER 1. INTRODUCTION .................................................................................. 1 1.1 A historical overview of ketamine ........................................................................................ 1 1.2 Structure and Chemistry ....................................................................................................... 3 1.3 Classical analgesic mechanisms of ketamine ...................................................................
    [Show full text]
  • Democratic Values and Democratic Support in East Asia
    Democratic Values and Democratic Support in East Asia Kuan-chen Lee [email protected] Postdoctoral fellow, Institute of Political Science, Academia Sinica Judy Chia-yin Wei [email protected] Postdoctoral fellow, Center for East Asia Democratic Studies, National Taiwan University Stan Hok-Wui Wong [email protected] Assistant Professor, Department of Applied Social Sciences, Hong Kong Polytechnic University Karl Ho [email protected] Associate Professor, School of Economic, Political, and Policy Sciences, University of Texas at Dallas Harold D. Clarke [email protected] Ashbel Smith Professor, School of Economic, Political, and Policy Sciences, University of Texas at Dallas Introduction In East Asia, 2014 was an epochal year for transformation of social, economic and political orders. Students in Taiwan and Hong Kong each led a large scale social movement in 2014 that not only caught international attention, but also profoundly influenced domestic politics afterwards. According to literature of political socialization, it is widely assumed that the occurrences of such a huge event will produce period effects which bring socio-political attitudinal changes for all citizens, or at least, cohort effects, which affect political views for a group of people who has experienced the event in its formative years. While existing studies have accumulated fruitful knowledge in the socio-political structure of the student-led movement, the profiles of the supporters in each movement, as well as the causes and consequences of the student demonstrations in the elections (Ho, 2015; Hawang, 2016; Hsiao and Wan, 2017; Stan, forthcoming; Ho et al., forthcoming), relatively few studies pay attention to the link between democratic legitimacy and student activism.
    [Show full text]
  • Quantification of Drugs for Drug-Facilitated Crimes in Human Urine
    Quantification of Drugs for Drug-Facilitated Crimes in Human Urine by Liquid Chromatography Tandem Mass Spectrometry Claudio De Nardi1, Anna Morando2, Anna Del Plato2 1Thermo Fisher Scientific, Dreieich, Germany; 2Ospedale “La Colletta”, Arenzano, Italy Overview TABLE 1. Concentrations of calibrators TABLE 3. Concentration range, intercept, slope and correlation factor (R2) Purpose: To implement a liquid chromatography tandem mass spectrometry method for forensic toxicology for the CAL CAL CAL CAL CAL CAL CAL Analyte Units Calibration quantification of drugs for drug-facilitated crimes in human 1 2 3 4 5 6 7 Analyte Intercept Slope R2 urine on a Thermo Scientific™ TSQ Access MAX™ triple stage Range Ketamine mass spectrometer; the method includes ketamine, its Ketamine 5 – 200 ng/mL -0.002 0.004 0.999 metabolites norketamine and dehydronorketamine, Norketamine phencyclidine and γ-butyrolactone (GBL); the method is also Norketamine 5 – 200 ng/mL 0.000 0.003 0.998 Dehydro ng/mL 5 10 20 50 100 200 N/A suitable for the detection of γ-hydroxybutyric acid (GHB) at norketamine Dehydronorketamine 5 – 200 ng/mL -0.001 0.002 0.999 physiological levels. Phencyclidine Phencyclidine 5 – 200 ng/mL 0.000 0.003 0.999 Methods: Following extraction using three volumes of GBL µg/mL 1 2 5 10 20 50 100 GBL 1 – 100 µg/mL -0.001 0.008 0.999 methanol containing 0.1% formic acid, samples were injected onto a Thermo Scientific™ Accela™ 600 HPLC system connected to a TSQ Access MAX triple stage mass Mass Spectrometry Figure 1. Calibration curve forGBL GBL spectrometer using a heated electrospray source.
    [Show full text]
  • Multilevel Spatial Impact Analysis of High-Speed Rail and Station Placement: a Short-Term Empirical Study of the Taiwan HSR
    T J T L U http://jtlu.org V. 13 N. 1 [2020] pp. 317–341 Multilevel spatial impact analysis of high-speed rail and station placement: A short-term empirical study of the Taiwan HSR Yu-Hsin Tsai Jhong-yun Guan National Chengchi University Dept. of Urban Development, Taipei City [email protected] Government [email protected] Yi-hsin Chung Dept. of Urban Development, Taipei City Government [email protected] Abstract: Understanding the impact of high-speed rail (HSR) services Article history: on spatial distributions of population and employment is important for Received: September 15, 2019 planning and policy concerning HSR station location as well as a wide Received in revised form: May range of complementary spatial, transportation, and urban planning 14, 2020 initiatives. Previous research, however, has yielded mixed results into the Accepted: May 26, 2020 extent of this impact and a number of influential factors rarely have been Available online: November 4, controlled for during assessment. This study aims to address this gap 2020 by controlling for socioeconomic and transportation characteristics in evaluating the spatial impacts of HSR (including station placement) at multiple spatial levels to assess overall impact across metropolitan areas. The Taiwan HSR is used for this empirical study. Research methods include descriptive statistics, multilevel analysis, and multiple regression analysis. Findings conclude that HSR-based towns, on average, may experience growing population and employment, but HSR-based counties are likely to experience relatively less growth of employment in the tertiary sector. HSR stations located in urban or suburban settings may have a more significant spatial impact.
    [Show full text]
  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
    Supplemental Material can be found at: /content/suppl/2020/12/18/73.1.202.DC1.html 1521-0081/73/1/202–277$35.00 https://doi.org/10.1124/pharmrev.120.000056 PHARMACOLOGICAL REVIEWS Pharmacol Rev 73:202–277, January 2021 Copyright © 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: MICHAEL NADER Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss Antonio Inserra, Danilo De Gregorio, and Gabriella Gobbi Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Quebec, Canada Abstract ...................................................................................205 Significance Statement. ..................................................................205 I. Introduction . ..............................................................................205 A. Review Outline ........................................................................205 B. Psychiatric Disorders and the Need for Novel Pharmacotherapies .......................206 C. Psychedelic Compounds as Novel Therapeutics in Psychiatry: Overview and Comparison with Current Available Treatments . .....................................206 D. Classical or Serotonergic Psychedelics versus Nonclassical Psychedelics: Definition ......208 Downloaded from E. Dissociative Anesthetics................................................................209 F. Empathogens-Entactogens . ............................................................209
    [Show full text]
  • Ketamine Homogeneous Enzyme Immunoassay (HEIA™)
    Ketamine Homogeneous Enzyme Immunoassay (HEIA™) Exclusively from Immunalysis Formula: C13H16CINO Semi-Quantitative or Qualitative Testing Systematic Name: (RS)- 2- (2- chlorophenyl)- 2- (methylamino)cyclohexanone Accurate and reliable Brand Names: Ketanest®, Ketaset®, Ketalar® Ready to use About Ketamine: Ketamine is an anesthetic agent used in the United States since 1972 for veterinary and pediatric medicine. It is also used in the treatment of depression and postoperative pain management. However, in recent years it has gained popularity as a street drug used at clubs and raves due to its hallucinogenic effects. Administration: Oral; intravenous; intramuscular; insufflation Elimination: Ketamine metabolizes by N-demethylation to Norketamine and further dehydrogenates to Dehydronorketamine. After 72 hours of a single dose, 2.3% of Ketamine is unchanged, 1.6% is Norketamine, 16.2% is Dehydronorketamine, and 80% is hydroxylated derivatives of Ketamine.1,2 Abuse Potential: An overdose can cause unconsciousness and dangerously slowed breathing. 1) R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, Fourth Edition, p. 412-414. 2) K. Moore, J.Skerov, B.Levine, and A.Jacobs, Urine Concentrations of Ketamine and Norketamine Following Illegal Consumption, J.Anal, Toxicol. 25: 583-588 (2001). Ketanest® is a registered trademark of Pfizer, Inc., Ketaset® is a trademark of ZOETIS W LLC., Ketalar® is a trademark of PAR STERILE PRODUCTS, LLC. Tel 909.482.0840 | Toll Free 888.664.8378 | Fax 909.482.0850 ISO13485:2003 www.immunalysis.com CERTIFIED
    [Show full text]
  • A Clickable Analogue of Ketamine Retains NMDA Receptor Activity
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2016 A clickable analogue of ketamine retains NMDA receptor activity, psychoactivity, and accumulates in neurons Christine Emnett Washington University School of Medicine in St. Louis Hairong Li Washington University School of Medicine in St. Louis Xiaoping Jiang Washington University School of Medicine in St. Louis Ann Benz Washington University School of Medicine in St. Louis Joseph Boggiano Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Emnett, Christine; Li, Hairong; Jiang, Xiaoping; Benz, Ann; Boggiano, Joseph; Conyers, Sara; Wozniak, David F.; Zorumski, Charles F.; Reichert, David E.; and Mennerick, Steven, ,"A clickable analogue of ketamine retains NMDA receptor activity, psychoactivity, and accumulates in neurons." Scientific Reports.6,. (2016). https://digitalcommons.wustl.edu/open_access_pubs/5464 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Christine Emnett, Hairong Li, Xiaoping Jiang, Ann Benz, Joseph Boggiano, Sara Conyers, David F. Wozniak, Charles F. Zorumski, David E. Reichert, and Steven Mennerick This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/5464 www.nature.com/scientificreports OPEN A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Received: 15 June 2016 Accepted: 15 November 2016 Neurons Published: 16 December 2016 Christine Emnett1,2,*, Hairong Li3,*, Xiaoping Jiang1, Ann Benz1, Joseph Boggiano1, Sara Conyers1, David F.
    [Show full text]
  • RESEARCH PROTOCOL Role of CYP2B6 Polymorphisms In
    RESEARCH PROTOCOL Role of CYP2B6 polymorphisms in ketamine metabolism and clearance Evan D. Kharasch, M.D., Ph.D. Russell D. and Mary B. Shelden Professor of Anesthesiology Director, Division of Clinical and Translational Research Washington University School of Medicine Department of Anesthesiology 660 S. Euclid Ave., Campus Box 8054 St. Louis, Mo. 63110 Voice: (314) 362-8796 Fax: (314) 747-3371 E-mail: [email protected] Original Version: July 9, 2013 2 1. SYNOPSIS Study Title Role of CYP2B6 polymorphisms in ketamine metabolism and clearance Objective To determine the effects of cytochrome P4502B6 (CYP2B6) genetic variants on ketamine metabolism and clearance Study Design Single-center, open label, single-session study to evaluate ketamine pharmaco- kinetics in subjects with known CYP2B6 genotype Study Period Planned enrollment duration: Approximately 3 months. Planned study duration: 1 day per subject Number of Patients Approximately 40 healthy volunteers identified by CYP2B6 genotyping by HRPO-approved screening Inclusion and Inclusion Criteria Exclusion Criteria a) 18-50 yr old b) CYP2B6*1/*1, CYP2B6*1/*6 or CYP2B6*6/*6 genotype c) Good general health with no remarkable medical conditions d) BMI < 33 e) Provide informed consent Exclusion Criteria a) Known history of liver or kidney disease b) Use of prescription or non-prescription medications, herbals, foods or chemicals known to be metabolized by or affecting CYP2B6 c) Females who are pregnant or nursing d) Known history of drug or alcohol addiction (prior or present addiction or treatment for addiction) e) Direct physical access to and routine handling of addicting drugs in the regular course of duty (a routine exclusion from studies of drugs with addiction potential) Study Medication Subjects will be studied on one occasion at Washington University in St.
    [Show full text]
  • Toxic, and Comatose-Fatal Blood-Plasma Concentrations (Mg/L) in Man
    Therapeutic (“normal”), toxic, and comatose-fatal blood-plasma concentrations (mg/L) in man Substance Blood-plasma concentration (mg/L) t½ (h) Ref. therapeutic (“normal”) toxic (from) comatose-fatal (from) Abacavir (ABC) 0.9-3.9308 appr. 1.5 [1,2] Acamprosate appr. 0.25-0.7231 1311 13-20232 [3], [4], [5] Acebutolol1 0.2-2 (0.5-1.26)1 15-20 3-11 [6], [7], [8] Acecainide see (N-Acetyl-) Procainamide Acecarbromal(um) 10-20 (sum) 25-30 Acemetacin see Indomet(h)acin Acenocoumarol 0.03-0.1197 0.1-0.15 3-11 [9], [3], [10], [11] Acetaldehyde 0-30 100-125 [10], [11] Acetaminophen see Paracetamol Acetazolamide (4-) 10-20267 25-30 2-6 (-13) [3], [12], [13], [14], [11] Acetohexamide 20-70 500 1.3 [15] Acetone (2-) 5-20 100-400; 20008 550 (6-)8-31 [11], [16], [17] Acetonitrile 0.77 32 [11] Acetyldigoxin 0.0005-0.00083 0.0025-0.003 0.005 40-70 [18], [19], [20], [21], [22], [23], [24], [25], [26], [27] 1 Substance Blood-plasma concentration (mg/L) t½ (h) Ref. therapeutic (“normal”) toxic (from) comatose-fatal (from) Acetylsalicylic acid (ASS, ASA) 20-2002 300-3502 (400-) 5002 3-202; 37 [28], [29], [30], [31], [32], [33], [34] Acitretin appr. 0.01-0.05112 2-46 [35], [36] Acrivastine -0.07 1-2 [8] Acyclovir 0.4-1.5203 2-583 [37], [3], [38], [39], [10] Adalimumab (TNF-antibody) appr. 5-9 146 [40] Adipiodone(-meglumine) 850-1200 0.5 [41] Äthanol see Ethanol -139 Agomelatine 0.007-0.3310 0.6311 1-2 [4] Ajmaline (0.1-) 0.53-2.21 (?) 5.58 1.3-1.6, 5-6 [3], [42] Albendazole 0.5-1.592 8-992 [43], [44], [45], [46] Albuterol see Salbutamol Alcuronium 0.3-3353 3.3±1.3 [47] Aldrin -0.0015 0.0035 50-1676 (as dieldrin) [11], [48] Alendronate (Alendronic acid) < 0.005322 -6 [49], [50], [51] Alfentanil 0.03-0.64 0.6-2.396 [52], [53], [54], [55] Alfuzosine 0.003-0.06 3-9 [8] 2 Substance Blood-plasma concentration (mg/L) t½ (h) Ref.
    [Show full text]